跳至主要内容
临床试验/PER-012-14
PER-012-14未知未知

INTERNATIONAL STUDY OF COMPARATIVE HEALTH EFFECTIVENESS WITH MEDICAL AND INVASIVE APPROACHES. ISCHEMIA.

ational Heart, Lung, and Blood Institute,0 个研究点目标入组 0 人开始时间: 2014年5月22日最近更新:
适应症

试验速览

阶段
未知
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
21 至 99(—)

入选标准

  • At least moderate ischemia on a stress imaging test with nuclear myocardial perfusion (≥10% myocardium), echo or cardiac magnetic resonance wall motion (≥3/16 segments with stress-induced severe hypokinesis or akinesis), or cardiac magnetic resonance perfusion (≥12% myocardium). Participant is willing to comply with all aspects of the protocol, including adherence to medical therapy and follow-up visits. Participant is willing to give written informed consent. Age ≥ 21 years

排除标准

  • LVEF < 35% History of unprotected left main stenosis >50% on prior coronary computed tomography angiography (CCTA) or prior cardiac catheterization (if available). Finding of no obstructive CAD” (<50% stenosis in all major epicardial vessels) on prior CCTA or prior catheterization, performed within 12 months Prior known coronary anatomy unsuitable for either PCI or CABG Unacceptable level of angina despite maximal medical therapy Very dissatisfied with medical management of angina History of noncompliance with medical therapy Acute coronary syndrome within the previous 2 months PCI or CABG within the previous 12 months Stroke within the previous 6 months or intracranial hemorrhage at any time History of ventricular tachycardia requiring therapy for termination, or symptomatic sustained ventricular tachycardia NYHA class III-IV heart failure at entry or hospitalization for exacerbation of chronic heart failure within the previous 6 months Non-ischemic dilated or hypertrophic cardiomyopathy End stage renal disease on dialysis or estimated glomerular filtration rate (eGFR) <30mL/min. (Please, check the 5.3 Protocol section).

研究者

发起方
ational Heart, Lung, and Blood Institute,

相似试验